Most comparisons start with a provider and ask what it costs. This one inverts the question: fix the budget at $200 a month and ask what each provider actually hands you for that money. It surfaces differences that a price-ordered list hides.
Key Takeaways
- At $200/month, oral and sublingual formats buy you a maintenance-capable dose at several providers.
- At the same budget, injectable options are more constrained and often require a plan-length commitment.
- Tirzepatide at $200/month is available at a smaller set of providers than semaglutide.
- Coaching, nausea support and included extras vary enormously at an identical price point.
- Two providers at the same monthly number can differ by hundreds of dollars a year once billing cycles and dose tiers are accounted for.
How we built this table
Every figure here comes from the provider's own published pricing or intake flow as of our most recent verification pass. Where a provider publishes a range rather than a single number, we show the range. Where pricing only appears after you complete an intake, we say so rather than guessing. We do not estimate, average, or fill gaps — a blank is a blank.
Prices in this category move often. Treat this table as a starting shortlist and confirm the current number at checkout before you commit to a multi-month plan.
| Provider | What $200/month gets you | Format | Included beyond the medication |
|---|---|---|---|
| Wellorithm | Oral semaglutide at the published $147 rate, with headroom left over | Oral tablet | Clinical review; injectable available separately |
| MadeMed | Oral semaglutide from $99, or injectable semaglutide at $179 starting tier | Sublingual or injectable | Membership program available for refill discounts |
| Found Health | Dissolvable semaglutide at $189 per 4-week cycle | Dissolvable tablet | Behavior-change coaching bundled |
| Telos Rx | Depends on plan length — long plans land under $200, short plans do not | Injectable | Cancel anytime; FSA/HSA |
| Yucca Health | Under budget only on the 6-month plan promo rate | Injectable | Free UPS 2-Day Air; financing options |
| SHED | Injectable or lozenge at the $199 entry rate | Injectable / lozenge / drops | 120-day guarantee terms; brand options at higher tiers |
| Strut Health ⚠️ | Sublingual semaglutide with substantial headroom | Sublingual lozenge | Async intake |
| Sesame Care | A brand-name oral Wegovy path at the low end of its $149–$299 band | Brand oral | Marketplace clinician access; brand-name products only |
Where the $200 line falls awkwardly
Two structural quirks make this budget an unusually revealing test point.
Four-week billing. A provider charging $189 per four-week cycle bills thirteen times a year, not twelve. That is roughly $2,457 annually against $2,268 for a $189 monthly plan — a $189 difference for an identical headline number. Found Health is the example in this table; check the cycle length anywhere you see a price described "per supply" rather than "per month."
Plan-length gating. Several providers can come in under $200 but only on a long commitment. Telos and Yucca both fall into this category. Under-budget on a twelve-month plan and over-budget month-to-month is a meaningfully different offer, even though a comparison table shows one number.
MadeMed (Injectable Semaglutide)
Injectable- Monthly and quarterly billing options
- L-carnitine included in the injectable formulation
- Membership program available for refill discounts
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Wellorithm
Lowest published oral price- Compounded tablet format — no needles, no cold chain
- Publishes per-format pricing rather than bundling everything into one plan
- Injectable options also offered
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Found Health
4-week billing cycle- Bills in 4-week cycles, not calendar months — 13 cycles a year, not 12
- Behavior-change coaching bundled with the medication track
- Dissolvable tablet format
A 4-week cycle means your true annual cost is 13 × the quoted price. Worth doing the multiplication before comparing against a monthly-billed competitor.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Tirzepatide at this budget
Tirzepatide pricing generally sits above semaglutide across the market, and $200 is a tighter fit. The oral tirzepatide options published at $229 sit just above the line. Injectable tirzepatide from $189 at the starting tier fits, but tiered pricing means it will not stay there as you escalate.
If tirzepatide specifically is your requirement and $200 is a hard ceiling, the flat-price plan-length structures are the ones worth examining closely, because they are the only structures that hold the number steady through escalation.
MadeMed (Injectable Tirzepatide)
Injectable- Priced close to the semaglutide line rather than at a large premium
- Quarterly billing lowers the effective monthly rate
- Dose increases are priced per tier — confirm your tier at checkout
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Telos Rx (Tirzepatide)
Flat pricing by plan length- Price is flat regardless of dose tier once your plan is set
- 12-month plan carries the lowest monthly rate; 1-month is the highest
- Cancel anytime; FSA/HSA accepted
Telos publishes plan-length pricing rather than dose-tier pricing, so the number you see at signup depends on the commitment you choose, not the milligrams you take.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
SHED
Multi-format- Carries brand-name options alongside compounded: Wegovy pen $199, oral Wegovy pill $149, Zepbound $349 plus a $99 membership
- 120-day results guarantee (terms updated June 10, 2026)
- Multi-month terms convert to a different ongoing rate — read the conversion language
Price-jump disclosure: SHED's tirzepatide pricing increases to $399/mo once you reach the 7.5 mg maintenance tier. Budget for the higher number, not the entry number.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Frequently Asked Questions
Can you get tirzepatide for $200 a month?
At the starting dose tier, some providers publish rates under $200. Whether it stays under $200 as you escalate depends entirely on whether the provider uses flat or tiered pricing.
Is $200 a month a realistic budget?
Based on published rates in this table, yes for several oral options and for injectable options on longer plans. It is tighter for month-to-month injectable plans and for higher tirzepatide doses.
Does a lower price mean a lower-quality product?
Price does not reliably indicate compounding quality either way. What matters more is which pharmacy prepares the medication, whether it is a 503A or 503B facility, and what documentation the provider will give you.
Do any of these include lab work?
Lab requirements vary. Where labs are required and not included, that is a real cost that does not appear in the monthly price.